Cite
HARVARD Citation
Nishioka, Y. et al. (n.d.). 492PA multicenter phase II trial to evaluate the efficacy of mFOLFOX6+cetuximab as induction chemotherapy to achieve R0 surgical resection for advanced colorectal liver metastases (NEXTO trial). Annals of oncology. p. . [Online].